The treatment, developed by Regeneron Pharmaceuticals, is for a very rare form of deafness. But it represents a medical milestone.
The FDA gives the green light to the first gene therapy for deafness
The treatment, developed by Regeneron Pharmaceuticals, is for a very rare form of deafness. But it represents a medical milestone.
The sector recorded 12 bankruptcy filings in the first quarter, up 33% from the fourth quarter of 2025, according to the analysis by Gibbins Advisors.
A Dutch cruise ship with about 150 passengers is waiting for help off Cape Verde after a suspected hantavirus outbreak killed three people
Recent court decisions could mean tens of millions of taxpayers are owed, the Taxpayer Advocate Service warns.